Prolonged Survival in a Non-Small Cell Lung Cancer with Brain Metastasis Treated with a Brain Mass Evacuation and Gefi tinib
Mardiah Suci Hardianti(1*), Johan Kurnianda(2)
(1) 
(2) 
(*) Corresponding Author
Abstract
Keywords
Full Text:
PDFReferences
Wen PY, MB P, Loeffl er J. Metastatic Brain Cancer.Wen PY, MB P, Loeffl er J (Eds). Lippincott Williams and Wilkins, PA, USA,
Gaspar LE, Mehta MP, Patchell RA et al. The role of whole brain radiation therapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J. Neurooncol . 2010. 96(1), 17–32.
Bartolotti M, Franceschi E, Brandes AA. EGF Receptor Tyrosine Kinase Inhibitors in the Treatment of Brain Metastases From Non-small-cell Lung Cancer. Expert Rev Anticancer Ther . 2012. 12(11):1429-1435.
Muldoon LL, Soussain C, Jahnke K et al. Chemotherapy delivery issues in central nervous system malignancy: a reality check. J. Clin. Oncol. 2007. 25(16), 2295–2305. 5. Gridelli C, Ciardiello F, Gallo C, Feld R, Butts C, Gebbia V, Maione P et al. Firstline erlotinib followed by second-line cisplatin-gemcitabine chemotherapy in advanced non-small-cell lung cancer: the TORCH randomized trial. J Clin Oncol. 2012 Aug 20;30(24):3002-11
Maemondo M, Inoue A, Kobayashi K, Sugawara S, Oizumi S, Isobe H, Gemma A et al. Gefi tinib or Chemotherapy for Non– Small-Cell Lung Cancer with Mutated EGFR. N Engl J Med. 2010;362:2380-8.
Sequist LV, Bell DW, Lynch TJ, Haber DA. Molecular predictors of response to epidermal growth factor receptor
antagonists in non-small-cell lung cancer. J Clin Oncol. 2007 Feb 10. 25(5):587-95.
Pao W, Miller VA, Politi KA, et al. Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain. PLoS Med. 2005 Mar. 2(3):e73.
Sequist LV, Waltman BA, Dias-Santagata D, Digumarthy S, Turke AB et al. Sci Transl Med. 2011 March 23; 3(75): 75ra26.
doi:10.1126/scitranslmed.3002003.
DOI: https://doi.org/10.22146/acta%20interna.22393
Article Metrics
Abstract views : 1580 | views : 749Refbacks
- There are currently no refbacks.
Copyright (c) 2017 Acta Interna The Journal of Internal Medicine
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Acta Interna The Journal of Internal Medicine Indexed by:
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.